Balancing on One Leg Is Most Reliable Measure of Neuromuscular Aging
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 -- Duration of one-legged balance is the most reliable measure of neuromuscular aging for both older men and women, according to a study published online Oct. 23 in PLOS ONE.
Asghar Rezaei, Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues investigated potential age-related declines in gait, balance, and strength, and assessed any relationships between the three parameters, as well as potential differences between women and men. The analysis included 40 healthy individuals older than 50 years.
The researchers found that gait parameters were not significantly affected by age, while knee and grip strength, along with several balance parameters, showed a significant decline with age. While all individuals were able to maintain bipedal balance, their center of pressure movement increased significantly by age. Compared with other factors, unipedal stance time was found to be the most affected by age. Per decade, the duration of unipedal balance declined by −0.62 standard deviations for the nondominant side and −0.53 for the dominant side. Sex differences were only seen for strength parameters, but did not impact the decline in balance parameters.
"The importance of balance, especially in unipedal stance, arises from the fact that it requires multiple sensory inputs and neuromuscular control, in addition to adequate muscle strength," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-24 12:00
Read more
- Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
- Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
- President-Elect Trump to Pick Mehmet Oz to Head CMS
- Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
- Spinal Cord Stimulation Holds Promise for Chronic Pain
- Antiviral Treatment Underutilized for Children, Teens With Flu
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions